1. Home
  2. SLGL vs FCT Comparison

SLGL vs FCT Comparison

Compare SLGL & FCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sol-Gel Technologies Ltd.

SLGL

Sol-Gel Technologies Ltd.

HOLD

Current Price

$69.80

Market Cap

247.1M

Sector

Health Care

ML Signal

HOLD

Logo First Trust Senior Floating Rate Income Fund II of Beneficial Interest

FCT

First Trust Senior Floating Rate Income Fund II of Beneficial Interest

HOLD

Current Price

$9.52

Market Cap

252.6M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
SLGL
FCT
Founded
1997
2004
Country
Israel
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Finance Companies
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
247.1M
252.6M
IPO Year
2016
N/A

Fundamental Metrics

Financial Performance
Metric
SLGL
FCT
Price
$69.80
$9.52
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$110.00
N/A
AVG Volume (30 Days)
17.5K
96.0K
Earning Date
03-19-2026
01-01-0001
Dividend Yield
N/A
11.29%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$223.84
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.40
$8.61
52 Week High
$97.97
$10.29

Technical Indicators

Market Signals
Indicator
SLGL
FCT
Relative Strength Index (RSI) 43.12 29.70
Support Level $66.47 $9.41
Resistance Level $71.43 $9.68
Average True Range (ATR) 10.59 0.08
MACD -1.55 -0.01
Stochastic Oscillator 19.72 7.02

Price Performance

Historical Comparison
SLGL
FCT

About SLGL Sol-Gel Technologies Ltd.

Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline includes SGT-610 (Patidegib Gel 2%), a new chemical entity hedgehog signaling pathway blocker, for the chronic use and prevention of new BCC in Gorlin syndrome patients, and the topical drug candidate SGT-210 for the treatment of Darier Disease and other rare keratosis-related indications such as PC, PPK and Olmsted.

About FCT First Trust Senior Floating Rate Income Fund II of Beneficial Interest

First Trust Senior Floating Rate Income Fund II is a United States-based diversified, closed-end management investment company. Its investment objective is to seek a high level of current income. As a secondary objective, it attempts to preserve capital. The fund invests in a portfolio of senior secured floating-rate corporate loans (Senior Loans) of companies from different industries, such as Insurance, Software, Health Care Providers and Services, Professional Services, Health Care Technology, IT Services, and others.

Share on Social Networks: